Kidney Stones Management Market is estimated to grow with a CAGR of 5.30% during the forecast period

Kidney Stones Management Market size was valued at USD 1.54 billion in 2020 and expected to expand to USD 2.57 billion at a compound annual growth rate (CAGR) of 5.30%.  Kidney stones, also known as urolithiasis or renal calculi, are hard deposits formed in the kidneys that are made up of salts and minerals. When the urine becomes concentrated, the minerals in the body crystallise, forming stones. The usage of certain supplements and drugs, as well as physical issues such as excess body weight, are the most common sources of such deposits. When the sediments obstruct the urinary tract, surgery is required to clear it. Percutaneous Nephrolithotomy, Uteroscopy, and Extracorporeal Shock Wave Lithotripsy are some of the procedures used to treat the stones (ESWL).

The report " Global Kidney Stones Management Market, By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, and Cysteine), By Application (Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

  • In March 2020, Medi-Tate, an Israeli medical device firm, gained FDA approval for their iTind system, which is used to implant and remove nitinol devices during bladder neck reconstruction.

Analyst View:

The global kidney stone management market has developed steadily over the years and is projected to continue growing in the near future. This is due to an increase in the prevalence and recurrence of kidney stones over the world. Extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy, and ureteroscopy are some of the treatments available in the worldwide kidney stone management market. ESWL is the one that is now gaining the most traction in the industry. This is due to the fact that shock waves used to treat kidney stones are non-invasive. And, as more small and efficient devices become available, the treatment is expected to become more popular.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3440

Key Market Insights from the report:

The Global Kidney Stones Management Market size was valued at USD 1.54 billion in 2020 and expected to expand to USD 2.57 billion at a compound annual growth rate (CAGR) of 5.30%. The global kidney stones management market report segments the market on the basis of type, application, and region.

  • Based on Type, Global Kidney Stones Management Market is segmented into Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, and Cysteine.
  • Based on Application, Global Kidney Stones Management Market is segmented into Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy.
  • By Region, the Global Kidney Stones Management Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Kidney Stones Management Market:

The key players operating in the Global Kidney Stones Management Market includes Allengers Medical Systems Ltd., Boston Scientific Corporation, R. Bard Inc., Karl Storz GmbH & Co. KG, Cook Medical, Coloplast Group, DirexGroup, Dornier MedTech, Olympus Corporation and Richard Wolf GmbH

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel,
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and
Read more